|
20/11/2019
|
Company Update: "New hospitals ramping up" -
Buy (TP Bt2.80)
|
|
18/11/2019
|
Earnings Brief: "3Q19: Beats estimates on strong revenue" - Buy (TP Bt2.80)
|
|
21/08/2019
|
Company Update: "Earnings on the path to growth" - Buy (TP Bt2.70)
|
|
15/08/2019
|
Earnings Brief: "2Q19: Beat estimates on better operations" -
Buy (TP Bt2.70)
|
|
18/07/2019
|
Company Update: "Weak 2Q19F, but uptrend to resume in 2H19" - Buy (TP Bt2.70)
|
|
11/06/2019
|
Company Update: "Earnings gaining ground" -
Buy (TP Bt2.70)
|
|
15/05/2019
|
Earnings Brief: "1Q19: Beat estimates" - Buy (TP Bt2.70)
|
|
02/04/2019
|
Company Update: "No ST lift - but shielded from price downside" - Buy (TP Bt2.70)
|
|
25/02/2019
|
Earnings Brief: "4Q18: Misses estimates" - Buy (TP Bt2.70)
|
|
19/11/2018
|
Company Update: "Negatives priced in" - Buy (TP Bt2.90)
|
|
12/11/2018
|
Earnings Brief: "3Q18: Weak quarter is not a trend" - Buy (TP Bt3.20)
|
|
26/09/2018
|
Company Update: "New earnings cycle begins" - Buy (TP Bt3.20)
|
|
03/09/2018
|
Company Update: "Operations strong, expansion no problem" - Buy (TP Bt2.90)
|
|
10/08/2018
|
Earnings Brief: "2Q18: Core profit beat market and met SCBS" - Buy (TP Bt2.90)
|
|
02/07/2018
|
Company Update: "Operations continue doing well" - Buy (TP Bt2.90)
|
|
11/05/2018
|
Earnings Brief: "1Q18: Beat thanks to cash patients" - Buy (TP Bt2.90)
|
|
26/02/2018
|
Earnings Brief: "4Q17: Weakened by non-recurring item" - Buy (TP Bt2.90)
|
|
12/12/2017
|
Company Update: "Price is over-penalized - buying opportunity" - Buy (TP Bt2.90)
|
|
10/11/2017
|
Earnings Brief: "3Q17: Slightly below SCBS but met market" - Buy (TP Bt3.50)
|
|
04/09/2017
|
Company Update: "2H17 looking good" - Buy (TP Bt3.50)
|
|
11/08/2017
|
Earnings Brief: "2Q17: Misses estimates on weaker revenue" - Buy (TP Bt3.50)
|
|
05/06/2017
|
Company Update: "Expansion done - time to play on earnings" - Buy (TP Bt3.50)
|
|
15/05/2017
|
Earnings Brief: "1Q17: In line with expectations" - Buy (TP Bt3.50)
|
|
20/03/2017
|
Company Update: "Play on strong earnings growth" - Buy (TP Bt3.50)
|
|
28/02/2017
|
Earnings Brief: "4Q16: Missed estimates on low revenue" - Buy (TP Bt3.50)
|
|
07/12/2016
|
Initiate Coverage: "Obstacles clearing, growth will get back on track" - Buy (TP Bt3.50)
|
| |
|
| |
|
FOLLOW US
SCB's Facbook INVX's Twitter